Inflammation is a hallmark of neurodegenerative diseases including multiple sclerosis (MS) and Alzheimer’s disease. The amyloid hypothesis still dominates in the conversation about what…
Vaxxinity’s beta-amyloid vaccine to treat Alzheimer’s disease — UB-311 — recently received fast track designation as it finishes up Phase 2 trials. Image: Vaxxinity…
The Food and Drug Administration issued an update to Aduhelm’s label, now requiring a total of four MRIs during the first year of treatment…
Biogen has withdrawn the application anti-amyloid Alzheimer’s drug Aduhelm from Europe’s regulatory agency. Biogen has abandoned its application for the approval of anti-amyloid Alzheimer’s…
Scientists are exploring the role of tau tangles in Alzheimer’s, and whether addressing these misfolded proteins could treat the disease. Here’s what you need…
Brain cells called oligodendrocytes wrap protective sheaths around neurons. But when that protection starts to break down, it may distract the brain’s cleaning crew,…
Scientists are studying brain cells called microglia to better understand the causes of Alzheimer’s — as well as new avenues for treatment. Imagine the…
Neurobiologist Karl Herrup shares his take on why the field of Alzheimer’s has struggled to find a cure, and what it would take to…
Clinical trials are recruiting younger, healthier participants for Alzheimer’s studies like the new TRAILBLAZER 3 donanemab clinical trial. Alzheimer’s is a notoriously difficult disease…
What’s the difference between treating Alzheimer’s symptoms and modifying the disease? Most FDA-approved Alzheimer’s drugs are designed just to address symptoms. Now, a new…
While recent work suggests personality traits may be associated with hallmarks of Alzheimer’s pathology, it does not show cause-and-effect or associate these hallmarks with…
Following the approval of the Alzheimer’s drug Aduhelm — and the litany of controversy surrounding it — one question that’s top of mind for…
Can Roche’s investigational anti-amyloid drug, gantenerumab, help slow down or even prevent Alzheimer’s disease? Trials are underway. The amyloid hypothesis—the idea that Alzheimer’s is…
A recent study of mice and humans indicates that breathing pure oxygen in highly pressurized chambers may improve cognitive impairment and reduce Alzheimer’s pathology….
In our LiveTalk series, Being Patient explored the inner workings of the Wisconsin Registry for Alzheimer’s Prevention, a long-running study of people at risk…